Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis-Reference-Cited by-同舟云学术

Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis

Published:2014-05-06 Issue:1 Volume:60 Page:334-348
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Granzow Michaela¹,Schierwagen Robert¹,Klein Sabine¹,Kowallick Benita¹,Huss Sebastian²,Linhart Markus³,Mazar Irela G. Reza⁴,Görtzen Jan¹,Vogt Annabelle¹,Schildberg Frank A.⁵,Gonzalez-Carmona Maria A.¹,Wojtalla Alexandra¹,Krämer Benjamin¹,Nattermann Jacob¹,Siegmund Sören V.¹,Werner Nikos³,Fürst Dieter O.⁴,Laleman Wim⁶,Knolle Percy⁵,Shah Vijay H.⁷,Sauerbruch Tilman¹,Trebicka Jonel¹

Affiliation:

1. Department of Internal Medicine I; University of Bonn; Bonn Germany

2. Department of Pathology; University of Bonn; Bonn Germany

3. Department of Internal Medicine II; University of Bonn; Bonn Germany

4. Institute for Cell Biology; University of Bonn; Bonn Germany

5. Institutes for Molecular Medicine and Experimental Immunology; University of Bonn; Bonn Germany

6. Department of Liver and Biliopancreatic disorders; University of Leuven; Leuven Belgium

7. Gastroenterology Research Unit and Cancer Cell Biology Program; Mayo Clinic; Rochester MN

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.27117/fullpdf

Reference46 articles.

1. Liver fibrosis;Bataller;J Clin Invest,2005

2. Mechanisms of hepatic fibrogenesis;Friedman;Gastroenterology,2008

3. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets;Gressner;J Cell Mol Med,2006

4. Myofibroblast-like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario;Parola;Mol Aspects Med,2008

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin II type-2 receptor attenuates liver fibrosis progression by suppressing IRE1α-XBP1 pathway;Cellular Signalling;2024-01

2. Navigating nonalcoholic fatty liver disease (NAFLD): Exploring the roles of estrogens, pharmacological and medical interventions, and life style;Steroids;2023-11

3. The renin-angiotensin-aldosterone system (RAAS) signaling pathways and cancer: foes versus allies;Cancer Cell International;2023-10-27

4. Liver endothelial cells in NAFLD and transition to NASH and HCC;Cellular and Molecular Life Sciences;2023-10-05

5. Altered splicing factor and alternative splicing events in a mouse model of diet- and polychlorinated biphenyl-induced liver disease;Environmental Toxicology and Pharmacology;2023-10